THIRD HARMONIC BIO INC's ticker is and the CUSIP is 88427A107. A total of 57 filers reported holding THIRD HARMONIC BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,928,264 | +32.8% | 5,779,071 | 0.0% | 0.78% | +55.6% |
| Q2 2023 | $27,797,332 | +16.7% | 5,779,071 | 0.0% | 0.50% | +7.9% |
| Q1 2023 | $23,809,773 | -4.2% | 5,779,071 | 0.0% | 0.47% | -1.7% |
| Q4 2022 | $24,850,005 | -77.3% | 5,779,071 | 0.0% | 0.48% | -76.7% |
| Q3 2022 | $109,629,000 | – | 5,779,071 | – | 2.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 10,907,859 | $44,940,379 | 6.08% |
| Stonepine Capital Management, LLC | 3,131,995 | $12,903,819 | 4.33% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $7,416,000 | 1.10% |
| BVF INC/IL | 4,365,933 | $17,987,644 | 0.66% |
| COMMODORE CAPITAL LP | 993,294 | $4,092,371 | 0.62% |
| Orbimed Advisors | 5,779,071 | $23,809,773 | 0.47% |
| Bain Capital Life Sciences Investors, LLC | 640,631 | $2,639 | 0.33% |
| EcoR1 Capital, LLC | 1,802,122 | $7,424,743 | 0.24% |
| GENERAL ATLANTIC, L.P. | 2,958,762 | $12,190,099 | 0.14% |
| Boxer Capital, LLC | 570,417 | $2,350 | 0.12% |